Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Launched by SEUNG-JUNG PARK · Aug 20, 2010

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of a new type of drug-eluting stent (a small tube used to keep arteries open) for patients with coronary artery disease. The researchers want to compare this new stent with older versions to see how well they work in everyday medical practice. If you have coronary artery disease and require a procedure called percutaneous coronary intervention (PCI), you might be eligible to participate in this study.

To join, you should not have any serious health issues that limit your treatment options, and you should not be using a mixture of different stents. If you decide to participate, you'll be monitored closely to see how well the new stent works for you compared to the others. This study is currently looking for participants of all ages, so if you or someone you know might be interested, it could be a good opportunity to contribute to important research in heart health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • coronary disease amenable to percutaneous coronary intervention (PCI)
• • no clinical and lesion limitations
• Exclusion Criteria:
• • patients with a mixture of several DES
• • terminal illness with life expectancy less than 1 year
• • patients with cardiogenic shock